SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001447028-21-000004
Filing Date
2021-02-17
Accepted
2021-02-17 16:52:11
Documents
2
Period of Report
2021-02-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_161359869528005.html 4  
1 FORM 4 wf-form4_161359869528005.xml 4 3881
2 POA - SOFIA poa-sofia.htm EX-24 3327
  Complete submission text file 0001447028-21-000004.txt   8765
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Issuer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ARBUTUS BIOPHARMA CORP. SUITE 100, 8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address
Sofia Michael J. (Reporting) CIK: 0001635324 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34949 | Film No.: 21645649